BioCentury
ARTICLE | Company News

Zhejiang Tianyuan, Novartis infectious, pharmaceuticals news

March 28, 2011 7:00 AM UTC

Novartis completed its previously announced acquisition of an 85% stake in vaccine company Zhejiang Tianyuan for about RMB980 million ($150 million) in cash. Novartis, which previously said it would a...